According to her, the purchase of a certain amount of "Molnupiravir" was supported by the clinical group, and after the completion of the procedures it will become available:

"Recently, there has been a very active discussion and anticipation about the new, specifically, oral anticovid-19 drugs. One of them is "Molnupiravir" produced by "Merck", which is already used in several countries. The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s "Molnupiravir" for the treatment of mild-to-moderate coronavirus disease. We are working in this direction. The clinical team has supported the purchase of a certain amount of medicine and we think that as soon as the procurement procedure is completed, it will be available in the country," - Gabunia said.

According to Tamar Gabunia, the country may also receive the medicine produced by "Pfizer".